Update on National Partnership to Improve Dementia Care
The National Partnership to Improve Dementia Care in Nursing Homes released their latest update on Antipsychotic Medicare Use Data. The official measure of the Partnership is the percentage of long-stay nursing home residents who are receiving an antipsychotic medication, excluding those residents diagnosed with schizophrenia, Huntington's Disease or Tourette’s Syndrome.
In the fourth quarter of 2011, 23.9 percent of long-stay nursing home residents were receiving an antipsychotic medication; since then there has been a decrease of 34.1 percent to a national prevalence of 15.7 percent in the first quarter of 2017. Success has varied by state and the Centers for Medicare and Medicaid Services region, with some states and regions having seen a reduction of greater than 35 percent.
A four-quarter average of this measure is posted to the Nursing Home Compare website.